[1]
|
Camilleri M. Leaky gut: mechanisms, measurement and clinical implications in humans[J]. Gut, 2019, 68: 1516-1526. doi: 10.1136/gutjnl-2019-318427 |
[2]
|
中华医学会消化病学分会胃肠激素与黏膜屏障学组. 胃肠道黏膜保护临床专家共识(2021年, 福州)[J]. 中华消化杂志, 2021, 41: 798-811. doi: 10.3760/cma.j.cn311367-20210930-00524 |
[3]
|
Yandrapu H, Sarosiek J. Protective Factors of the Gastric and Duodenal Mucosa: An Overview[J]. Curr Gastroenterol Rep, 2015, 17: 24. doi: 10.1007/s11894-015-0452-2 |
[4]
|
Capaldo CT, Powell DN, Kalman D. Layered defense: how mucus and tight junctions seal the intestinal barrier[J]. J Mol Med (Berl), 2017, 95: 927-934. doi: 10.1007/s00109-017-1557-x |
[5]
|
Paone P, Cani PD. Mucus barrier, mucins and gut microbiota: the expected slimy partners?[J]. Gut, 2020, 69: 2232-2243. doi: 10.1136/gutjnl-2020-322260 |
[6]
|
Allam-Ndoul B, Castonguay-Paradis S, Veilleux A. Gut Microbiota and Intestinal Trans-Epithelial Permeability[J]. Int J Mol Sci, 2020, 21: 6402。 doi: 10.3390/ijms21176402 |
[7]
|
Wirth HP, Yang M. Different Pathophysiology of Gastritis in East and West?A Western Perspective[J]. Inflamm Intest Dis, 2016, 1: 113-122. doi: 10.1159/000446300 |
[8]
|
Guzmán-Mejía F, Godínez-Victoria M, Vega-Baurista A, et al. Intestinal Homeostasis under Stress Siege[J]. Int J Mol Sci, 2021, 22: 5095 doi: 10.3390/ijms22105095 |
[9]
|
杨莹韵, 李渊, 张海芳, 等. 北京地区慢性非萎缩性胃炎伴糜烂患者277例的病因及治疗现状[J]. 中华消化杂志, 2021, 41: 27-32. doi: 10.3760/cma.j.cn311367-20210718-00390 |
[10]
|
Watanabe T, Fujiwara Y, Chan FKL. Current knowledge on non-steroidal anti-inflammatory drug-induced small-bowel damage: a comprehensive review[J]. J Gastroenterol, 2020, 55: 481-495. doi: 10.1007/s00535-019-01657-8 |
[11]
|
Elting LS, Cooksley C, Chambers M, et al. The burdens of cancer therapy. Clinical and economic outcomes of chemo-therapy-induced mucositis[J]. Cancer, 2003, 98: 1531-1539. doi: 10.1002/cncr.11671 |
[12]
|
Chulkina M, Beswick EJ, Pinchuk IV. Role of PD-L1 in Gut Mucosa Tolerance and Chronic Inflammation[J]. Int J Mol Sci, 2020, 21: 9165. doi: 10.3390/ijms21239165 |
[13]
|
Gyires K, Laszlo SB, Lazar B, et al. Similar and Distinct Mechanisms in the Protective Processes of Upper and Lower Gastrointestinal Tract[J]. Curr Pharm Des, 2018, 24: 1936-1946. doi: 10.2174/1381612824666180516101531 |
[14]
|
Xiong L, Huang X, Li L, et al. Geranylgeranylacetone protects against small-intestinal injuries induced by diclofenac in patients with rheumatic diseases: a prospective randomized study[J]. Dig Liver Dis, 2015, 47: 280-284. doi: 10.1016/j.dld.2015.01.005 |
[15]
|
Kuramoto T, Umegaki E, Nouda S, et al. Preventive effect of irsogladine or omeprazole on non-steroidal anti-inflam-matory drug-induced esophagitis, peptic ulcers, and small intestinal lesions in humans, a prospective randomized controlled study[J]. BMC Gastroenterol, 2013, 13: 85. |
[16]
|
韩涛涛, 陈楚岩, 王静, 等. 瑞巴派特对非甾体抗炎药相关小肠黏膜损伤的保护机制[J]. 中华消化杂志, 2021, 41: 183-189. |